33
Views
5
CrossRef citations to date
0
Altmetric
Original article

Health technology assessment and implications for clinical practice: the case of prostate cancer screening

, , , , , , , & show all
Pages 331-338 | Received 25 Jun 2002, Accepted 03 Oct 2002, Published online: 08 Jul 2009

REFERENCES

  • Kreftregisteret. Cancer in Norway 1998. 2001. p. 1–105
  • IARC. Prostate cancer incidence and mortality. 2002.
  • Fossa SD, En i LM, Skovlund E, Tveter K, Vatten L. No randomised trial of prostate-cancer screening in Norway. Lancet Oncol 2001; 2(12): 741–745.
  • Schersten T, Baile M, Asua J, Jonsson E. Prostate Cancer Screening: Evidence Synthesis and Update Statements of Findings. INAHTA joint project, Vitoria-Gasteiz: Department of Health Basque Government 1999 (http://www.inahta.org/)
  • Fossa SD, En i L. Timely screening routines for prostatic cancer by Norwegian physicians. Tidsskr Nor Lxgeforen 1999; 119: 3572–3576.
  • Skovlund E, Fossa SD. PSA analyses in three Norwegian countries in 1999. Tidsskr Nor Lxgeforen 1999; 120: 2539–2541.
  • Myhre K, Fossa SD, Bjerklund Johansen T, Hoisxter P, Vatten L. Screening for prostatakreft, SMM rapport nr 3/1999. 1–31. 1999. Senter for medisinsk metodevurdering
  • Harbitz TB, Haugen OA. Histology of the prostate in elderly men. A study in an autopsy series. Acta Pathol Microbiol Scand [A] 1972; 80(6): 756–768.
  • Liavag I, Harbitz TB, Haugen OA. Latent carcinoma of the prostate. Recent Results Cancer Res 1972; 39: 131–137.
  • Bunting PS. Screening for prostate cancer with prostate-specific antigen: beware the biases. Clin Chim Acta 2002; 315(1-2): 71–97.
  • Richter F, Dudley AW Jr., Irwin RJ Jr., Sadeghi-Nejad H. Are we ordering too many PSA tests? Prostate cancer diagnosis and PSA screening patterns for a single Veterans Affairs Medical Center. J Cancer Educ 2001; 16(1): 38–41.
  • Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW. Factors influencing use of the prostate-specific antigen screening test in primary care. Am J Manag Care 2000; 6(3): 315— 324.
  • Melia J, Moss S. Survey of the rate of PSA testing in general practice. Br J Cancer 2001; 85(5): 656— 657.
  • SMM med stalinistiske metoder Legekunsten 11[3], 38–39. 2002
  • American Cancer Society 2002.(http://www.cancer.org/eprise/main/docroot/CRI/content/ CRI 2 2 3X How is prostate_cancer_found_36? sitearea = CRI) American Urological Association, september 2002: (https://shop.auanet.org/timssnet/ products/guidelines/patient_guides/prostate_aware-ness.pdf) National comprehensive cancer network, September 2002 (http://www.nccn.org/physician_gls/ index.html).
  • Barry MJ. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 2001; 344: 1373–7.
  • Chan EC, Sulmasy DP. What should men know about prostate-specific antigen screening before giving informed consent? Am J Med 1998; 105: 266— 74.
  • Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med 1996; 11: 342 — 9.
  • Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. Eff Clin Pract 2001; 4: 112–20.
  • Chan EC, Sulmasy DP. What should men know about prostate-specific antigen screening before giving informed consent? Am J Med 1998; 105: 266— 74.
  • Volk RJ, Spann SJ. Decision-aids for prostate cancer screening. J Fam Pract 2000; 49: 425–7.
  • Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 548–52.
  • Oliver SE, Gunnell D, Donovan JL. Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet 2000; 355(9217): 1788— 9.
  • de Koning HJ, Auvinen A, Berenguer SA, Calais dS, Ciatto S, Denis L, et al. Large-scale rando-mized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237–44.
  • Fossa SD, En i LM, Skovlund E, Tveter K, Vatten L. No randomised trial of prostate-cancer screen-ing in Norway. Lancet Oncol 2001; 2: 741–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.